Figure 4.
Impact of the different CAR-T treatment phases on everyday life and reasons for a substantial impact on everyday life.aN = 0, NR = 389; median: 13 to <19 months (IQR, 4 to <7 months - >2 to 3 years); bN = 0, NR = 385∗; median: 13 to < 19 months (IQR, 4 to <7 months - >2 to 3 years); cN = 8, NR = 381; median: 13 to <19 months (IQR, 4 to <7 months - >2 to 3 years); dN = 99, NR = 282; median: 19 to 24 months (IQR, 13 to <19 months - >2 to 3 years); eN = 63, NR = 219; median: >2 to 3 years (IQR, 13 to <19 months - >2 to 3 years); fN = 219. LD CHEMO, lymphodepleting chemotherapy.